Anterior distribution of stage T1c nonpalpable tumors in radical prostatectomy specimens

被引:73
|
作者
Takashima, R
Egawa, S
Kuwao, S
Baba, S
机构
[1] Kitasato Univ, Sch Med, Dept Urol, Kanagawa 2288555, Japan
[2] Kitasato Univ, Sch Med, Dept Pathol, Kanagawa 2288555, Japan
关键词
D O I
10.1016/S0090-4295(02)01525-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To determine the anatomic patterns of tumor distribution in radical prostatectomy specimens from nonpalpable prostate cancer. Methods. Tumor maps directly traced from histologic slides of 62 radical prostatectomy specimens were superimposed by a computer-assisted imaging technique to create an idealized prostate gland at three levels: apex, mid-prostate, and base. To investigate specific patterns of tumor distribution, the sites of tumor in each quadrant were compared according to risk group stratification. The tumor extent was compared with the patterns of positivity in routine sextant biopsies. Results. Among all patients, the tumor frequency was 85.5% in the mid-gland, 82.3% in the apex, and 48.4% in the base. Analysis by quadrant showed that tumors were significantly denser in the apex to mid-prostate. The primary extent of these tumors appeared to lie predominantly in the anterior half of the gland. Biopsy yields at the apex and mid-prostate appeared low compared with the frequency of cancers at these levels. No patterns specific to the different risk groups were found, but no tumors within the anterior base were found in the low-risk group. Conclusions. The primary extent of nonpalpable tumors appeared to lie predominantly in the anterior half of the gland at the apex to mid-prostate levels. Additional biopsy cores taken from more anterior regions of the gland may enhance the detection of nonpalpable cancers further. (C) 2002, Elsevier Science Inc.
引用
收藏
页码:692 / 697
页数:6
相关论文
共 50 条
  • [1] Comparative analysis of sampling methods for grossing radical prostatectomy specimens performed for nonpalpable (stage T1c) prostatic adenocarcinoma
    Sehdev, AES
    Pan, CC
    Epstein, JI
    HUMAN PATHOLOGY, 2001, 32 (05) : 494 - 499
  • [2] Long-term outcomes of nonpalpable prostate cancer (T1c) patients treated with radical prostatectomy
    Amiya, Yoshiyasu
    Sasaki, Makoto
    Shima, Takayuki
    Tomiyama, Yuusuke
    Suzuki, Noriyuki
    Murakami, Shino
    Nakatsu, Hiroomi
    Shimazaki, Jun
    PROSTATE INTERNATIONAL, 2015, 3 (01) : 27 - 30
  • [3] Clinicopathologic trends of patients with clinical stage T1C submitted to radical prostatectomy in Brazil
    Billis, A.
    Bronner, M. N.
    Galvao, M. F.
    Schultz, L.
    Magna, L. A.
    Ferreira, U.
    LABORATORY INVESTIGATION, 2007, 87 : 138A - 138A
  • [4] Clinicopathologic trends of patients with clinical stage T1c submitted to radical prostatectomy in Brazil
    Billis, A.
    Bronner, M. N.
    Galvao, M. F.
    Schultz, L.
    Magna, L. A.
    Ferreira, U.
    MODERN PATHOLOGY, 2007, 20 : 138A - 138A
  • [5] PATHOLOGICAL CHARACTERISTICS OF NONPALPABLE PROSTATE-CANCER (STAGE T1C)
    CHANEY, TL
    JENNINGS, S
    AUSTENFELD, MS
    GARCIA, FU
    LABORATORY INVESTIGATION, 1994, 70 (01) : A71 - A71
  • [6] Preoperative PSA and progression-free survival after radical prostatectomy for stage T1c disease
    Antenor, JAV
    Roehl, KA
    Eggener, SE
    Kundu, SD
    Han, M
    Catalona, WJ
    UROLOGY, 2005, 66 (01) : 156 - 160
  • [7] Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy
    Cookson, MS
    Fleshner, NE
    Soloway, SM
    Fair, WR
    UROLOGY, 1997, 49 (06) : 887 - 893
  • [8] Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer
    Pound, CR
    Walsh, PC
    Epstein, JI
    Chan, DW
    Partin, AW
    WORLD JOURNAL OF UROLOGY, 1997, 15 (06) : 373 - 377
  • [9] Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer
    Charles R. Pound
    Patrick C. Walsh
    Jonathan I. Epstein
    Daniel W. Chan
    Alan W. Partin
    World Journal of Urology, 1997, 15 : 373 - 377
  • [10] Pathological parameters of radical prostatectomy for at clinical stages T1c versus T2 prostate adenocarcinoma: Decreased pathological stage and increased detection of transition zone tumors
    Jack, GS
    Cookson, MS
    Coffey, CS
    Vader, V
    Roberts, RL
    Chang, SS
    Smith, JA
    Shappell, SB
    JOURNAL OF UROLOGY, 2002, 168 (02): : 519 - 524